Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II Combination Chemotherapy with ARA-C/Tetrahydrouridine for Patients with Chronic Myelocytic Leukemia in Blast Crisis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MDA-DT-7851
Last Modified:
3/20/2006
 
First Published:
1/23/2004
2.
Phase I Study of Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin in Combination With Radiotherapy Followed by Radiotherapy Alone in Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
Over 21
NCI
SCCC-2002033
NCI-6301, 6301, NCT00077051
Last Modified:
1/8/2008
 
First Published:
8/21/2007
3.
Phase I Study of Cytochlor, Tetrahydrouridine, and External-Beam Radiotherapy in Patients With Metastatic Carcinoma of the Brain
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Temporarily closed
21 and over
Other
SCCC-2005097
SCCC 2005097, SCCC-EPROST-20057104, SCCC-WIRB-20051340, NCT00521183
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute